Article

Guest editorial: The pandemic and young eyes

Perspectives from a pediatric ophthalmologist and mother.

Stacy Pineless

Screen time in our home quickly evolved from prepandemic “airplanes only” to “please go to your room and stay on your iPad all day while I work.”

On top of the iPad-as-babysitter approach to parenting that I employed throughout the pandemic, my children, like children across the country, switched from in-person learning to online school.

That meant the ample outdoor recess and physical education time they would otherwise get was gone.

Related: Editorial: Yes, ophthalmologists are real doctors

After-school sports and activities soon fell off the radar too, as did play-dates and beach time. We were left with indoor (largely electronic) activities 24-7. I am sure any parent reading this can relate!

As a pediatric ophthalmologist, with my own children: Did I institute a 20-20-20 rule in my home?

Adjust screen brightness or location? Mandate outdoor activity to prevent myopia progression?

I must admit — I did not.

Guest editorial: The pandemic and young eyes

However, at the office, the 20-20-20 rule became my mantra as I watched many of my patients progress over a full diopter of myopia within short 6-month courses.

I listened to parents as they described decompensation of intermittent exotropia, telling them to try pencil push-ups and take plenty of screen time breaks.

Related: Exploring possibilities of myopia control and prevention in the US

I pushed artificial tears and frequent screen breaks on children who reported dry eye symptoms (a disorder I rarely encountered before the pandemic). Yet at my own home, the children ran rampant on screens with no rules!

The proverb “the shoemaker’s children always go barefoot” probably applies to my experience.

As my patients return to in-person school, the complaints related to dry eye and decompensated phorias have diminished… but the progression of myopia appears to be permanent.

We will continue to study treatments for progressive myopia and hope to halt the epidemic of myopia in our youth.


Related: Myopia progression slowed with orthokeratology, multifocal lenses

In the meantime, I seem to have dodged a bullet at home — my 6-year-old daughter just passed her well-child vision screening with 20/20 vision OU.

However, the quality of the YouTube videos she has watched this year may have stunted her development elsewhere!

As parents, we all are doing the best we can, and I, for one, will be giving all parents the grace they need to accept the pandemic’s effects (and any “new rules” for screen-time they needed to survive this dark time) on their children’s eyes and move forward from here.

Read more editorials here

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Eric D. Donnenfeld, MD, on the effect of lifitegrast clinical signs and biomarkers in dry eye disease
(Image credit: Ophthalmology Times) The Residency Report: Clinical insights from the iStent infinite trial
(Image credit: Ophthalmology Times) ASCRS 2025: Jason Bacharach, MD, on early-onset efficacy with perfluorohexyloctane in dry eye
(Image credit: Ophthalmology Times) CCOI's new CEO Malvina Eydelman, MD, outlines her mission and vision for the organization
(Image credit: Ophthalmology Times) ASCRS 2025: Deb Ristvedt, DO, on medications, lasers, and lifestyle in glaucoma management
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
© 2025 MJH Life Sciences

All rights reserved.